Skip to content

Study, 1996

Can asthma get much worse right before your period?

Yes. One woman had life-threatening asthma attacks that only happened before her period. When a medication temporarily stopped her cycle, the attacks stopped.

Early or limited evidence One 41-year-old woman with long-standing severe asthma

What they did

Doctors reported a case of a 41-year-old woman with long-standing, severe asthma. She had life-threatening asthma attacks and doctors suspected they were linked to her menstrual cycle. They treated her with buserelin, a medication that creates temporary chemical menopause to see if this would stop the attacks.

What they found

Once the medication created chemical menopause, the woman no longer had life-threatening asthma attacks, suggesting they were linked to her menstrual cycle. The finding suggests estrogen and progesterone may be involved.

What it means for you

Some women with very severe asthma may have attacks specifically tied to their menstrual cycle. Stopping the cycle temporarily may help in these severe cases. The main limitation is this is only one person, so we do not know how common this is or if it would help other women.

1

Participant

41

Age of participant

About the study

Original title
Premenstrual Exacerbation of Life‐Threatening Asthma: Effect of Gonadotrophin Releasing Hormone Analogue Therapy
Authors
Alun L. Edwards, M Sarah Rose, Lois Donovan et al.
Journal
Canadian Respiratory Journal
Year
1996
Study design
Study
What was tested
Buserelin to create temporary chemical menopause
Open access
Yes
Original abstract

Variability in the severity of asthma during various phases of the menstrual cycle has been frequently suspected. However, the hormonal changes that might affect mediators of bronchospasm have yet to be elucidated. The case of a 41‐year‐old woman suffering from longstanding asthma with life‐threatening exacerbations is reported. The patient was treated with buserelin, a gonadotropin releasing hormone (GnRH) analogue, which created a temporary chemical menopause and thus permitted diagnosis of a premenstrual exacerbation of asthma and offered insight into potential therapy. GnRH analogues may therefore be of value in assessing women with severe asthma suspected to vary with the menstrual cycle. The addition of estrogens and progestins at the same time as treatment with GnRH analogue may be of value in determining the role of these hormones in the pathogenesis of menstrually related exacerbations of asthma.

Reproduced under CC-BY.

Topics